Silver Book Fact

In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.

The Expanding Pharmaceutical Arsenal in the War on Cancer. Working Paper No. 10328 Web site. http://www.nber.org/papers/w10328. Published Feb. 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
Working Paper No. 10328
Publisher
National Bureau of Economic Research
Publication Date
Published Feb. 2004
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a number of vaccines are being studied that would cause the body’s own immune system to fight cancer after it has…  
  • From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical…  
  • A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections,…  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.  
  • Studies have shown that annual mammograms reduce breast cancer related mortality in women by 20-40%.